Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data
1. Merck & Co, Inc., Kenilworth, United States of America;2. IMS Health Ltd, London, United Kingdom;3. Merck Sharp & Dohme Ltd, Hoddesdon, United Kingdom;Corvinus University of Budapest, HUNGARY